Tudor Investment Corp
MRSN

Tudor Investment Corp’s Mersana Therapeutics MRSN Stock Holding History

Tudor Investment Corp’s Portfolio MRSN Stock Details MRSN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,720
Closed -$271K – 2444
2022
Q1 		$271K Buy
+2,720
New +$318K 0.01% 1607
2021
Q3 		– Sell
-418
Closed -$142K – 2745
2021
Q2 		$142K Buy
+418
New +$158K ﹤0.01% 1515
2017
Q4 		– Sell
-800
Closed -$346K – 1197
2017
Q3 		$346K Sell
800
-2,031
-72% -$800K 0.02% 773
2017
Q2 		$989K Buy
+2,831
New +$979K 0.04% 341

Other funds holding MRSN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return